REQUEST A DEMO
Total
USD $0.00
Search more companies

Kedrion Betaphar Biyofarmasotik Ilac A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Kedrion Betaphar Biyofarmasotik Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2019 Available in: English Download a sample report

Kedrion Betaphar Biyofarmasotik Ilac A.S. is an enterprise in Turkiye, with the main office in Ankara. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on November 29, 2012. 13 (2023) employees currently work for Kedrion Betaphar Biyofarmasotik Ilac A.S.. There was a net sales revenue increase of 31.09% reported in Kedrion Betaphar Biyofarmasotik Ilac A.S.’s latest financial highlights for 2019. Its’ total assets recorded a growth of 405.03%. The net profit margin of Kedrion Betaphar Biyofarmasotik Ilac A.S. increased by 8.56% in 2019.

Headquarters
No:18-1 Cankaya Mahallesi Cemal Nadir Sokak Cankaya
Ankara; Central Anatolia; Postal Code: 06690

Contact Details: Purchase the Kedrion Betaphar Biyofarmasotik Ilac A.S. report to view the information.

Website: http://www.kedrion.com.tr

Basic Information
Total Employees:
Purchase the Kedrion Betaphar Biyofarmasotik Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Kedrion Betaphar Biyofarmasotik Ilac A.S. report to view the information.
Incorporation Date:
November 29, 2012
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Kedrion Betaphar Biyofarmasotik Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
31.09%
Total operating revenue
31.09%
Operating profit (EBIT)
82.59%
Net Profit (Loss) for the Period
253.06%
Total assets
405.03%
Total equity
5738.33%
Operating Profit Margin (ROS)
5.93%
Net Profit Margin
8.56%
Return on Equity (ROE)
-132.37%
Quick Ratio
0.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?